Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,510 | 415 | 99.8% |
| Education | $19.11 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,383 | 87 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,640 | 56 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,474 | 56 | $0 (2023) |
| Merck Sharp & Dohme LLC | $820.74 | 37 | $0 (2022) |
| Lilly USA, LLC | $628.30 | 25 | $0 (2023) |
| Novo Nordisk Inc | $607.93 | 30 | $0 (2023) |
| GlaxoSmithKline, LLC. | $598.79 | 24 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $375.59 | 10 | $0 (2019) |
| PFIZER INC. | $349.20 | 19 | $0 (2022) |
| Amgen Inc. | $321.99 | 10 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $58.12 | 3 | AstraZeneca Pharmaceuticals LP ($37.58) |
| 2023 | $443.53 | 20 | AstraZeneca Pharmaceuticals LP ($118.15) |
| 2022 | $773.21 | 37 | Boehringer Ingelheim Pharmaceuticals, Inc. ($260.40) |
| 2021 | $1,564 | 78 | Boehringer Ingelheim Pharmaceuticals, Inc. ($439.85) |
| 2020 | $1,238 | 56 | Janssen Pharmaceuticals, Inc ($354.79) |
| 2019 | $2,319 | 67 | AstraZeneca Pharmaceuticals LP ($809.07) |
| 2018 | $2,217 | 80 | AstraZeneca Pharmaceuticals LP ($555.74) |
| 2017 | $1,916 | 77 | AstraZeneca Pharmaceuticals LP ($467.34) |
All Payment Transactions
418 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Respiratory | ||||||
| 01/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Oncology | ||||||
| 12/20/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/14/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Diabetes | ||||||
| 11/30/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $29.15 | General |
| Category: Diabetes | ||||||
| 11/15/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: DIABETES | ||||||
| 11/01/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY, SHINGRIX | Food and Beverage | In-kind items and services | $29.26 | General |
| Category: RESPIRATORY | ||||||
| 10/12/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/27/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.42 | General |
| Category: Cardio-renal | ||||||
| 09/25/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Diabetes | ||||||
| 08/31/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 07/19/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: DIABETES | ||||||
| 06/08/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Diabetes | ||||||
| 06/05/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Respiratory | ||||||
| 05/17/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: VACCINES | ||||||
| 05/10/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Oncology | ||||||
| 04/10/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Respiratory | ||||||
| 04/04/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/28/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: DIABETES | ||||||
| 03/15/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Diabetes | ||||||
| 02/16/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: DIABETES | ||||||
| 02/09/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/01/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: DIABETES | ||||||
| 11/18/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 307 | 435 | $91,783 | $25,965 |
| 2022 | 8 | 438 | 696 | $106,221 | $40,421 |
| 2021 | 7 | 404 | 654 | $87,364 | $41,480 |
| 2020 | 6 | 415 | 721 | $84,545 | $30,938 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 130 | 241 | $51,431 | $12,755 | 24.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 54 | 69 | $21,117 | $6,440 | 30.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 61 | 62 | $13,646 | $4,689 | 34.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 62 | 63 | $5,589 | $2,081 | 37.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 174 | 416 | $77,884 | $24,521 | 31.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 82 | 86 | $6,289 | $6,022 | 95.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 53 | $12,971 | $3,926 | 30.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 83 | 87 | $4,301 | $3,140 | 73.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 11 | 11 | $2,365 | $1,697 | 71.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 16 | 16 | $741.60 | $579.76 | 78.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 15 | 15 | $1,283 | $427.45 | 33.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 12 | $385.92 | $108.87 | 28.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 171 | 413 | $60,464 | $25,261 | 41.8% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 76 | 76 | $5,396 | $5,049 | 93.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 34 | 41 | $8,567 | $4,151 | 48.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 17 | $4,724 | $2,508 | 53.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 14 | 14 | $3,200 | $2,195 | 68.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 78 | 78 | $3,741 | $1,631 | 43.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 15 | 15 | $1,272 | $684.40 | 53.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 177 | 478 | $66,920 | $20,724 | 31.0% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 92 | 92 | $5,980 | $5,610 | 93.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 21 | 25 | $5,000 | $2,040 | 40.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 97 | 97 | $4,365 | $1,996 | 45.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 14 | 14 | $630.00 | $287.03 | 45.6% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 14 | 15 | $1,650 | $280.73 | 17.0% |
About Dr. Ann Omachi, MD
Dr. Ann Omachi, MD is a Internal Medicine healthcare provider based in Daly City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780743740.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ann Omachi, MD has received a total of $10,529 in payments from pharmaceutical and medical device companies, with $58.12 received in 2024. These payments were reported across 418 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($10,510).
As a Medicare-enrolled provider, Omachi has provided services to 1,564 Medicare beneficiaries, totaling 2,506 services with total Medicare billing of $138,804. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Daly City, CA
- Active Since 12/06/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1780743740
Products in Payments
- FARXIGA (Drug) $1,595
- JARDIANCE (Drug) $1,335
- XARELTO (Drug) $1,087
- INVOKANA (Drug) $550.29
- TRULICITY (Drug) $457.65
- JANUVIA (Drug) $394.21
- ENTRESTO (Drug) $375.59
- Ozempic (Drug) $317.68
- BEVESPI AEROSPHERE (Drug) $260.67
- STEGLATRO (Drug) $238.04
- TRELEGY ELLIPTA (Drug) $232.13
- PREVNAR 13 (Biological) $212.05
- XIFAXAN (Drug) $201.10
- Repatha (Biological) $185.97
- BYDUREON (Drug) $176.84
- NURTEC ODT (Drug) $151.77
- FASENRA (Drug) $138.01
- TRADJENTA (Drug) $132.04
- NEXLETOL (Drug) $117.93
- Creon (Drug) $111.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Daly City
Kevin Wong, M.d, M.D
Internal Medicine — Payments: $45,517
Tony Wong, M.d, M.D
Internal Medicine — Payments: $40,235
Dr. John Lai, M.d, M.D
Internal Medicine — Payments: $39,667
Dr. Alice Yan, M.d, M.D
Internal Medicine — Payments: $22,968
Damon Lee, Md, MD
Internal Medicine — Payments: $20,608
Dr. Shu May Lee, M.d, M.D
Internal Medicine — Payments: $18,620